{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from rnaseq_lib.web import openfda_get_drugs_by_query\n",
    "from rnaseq_lib.web import openfda_drug_label\n",
    "from rnaseq_lib.web import _rget\n",
    "from rnaseq_lib.utils.expando import Expando\n",
    "\n",
    "import pandas as pd\n",
    "import os\n",
    "from collections import defaultdict\n",
    "\n",
    "from progressbar import ProgressBar"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Table\n",
    "\n",
    "1. Get list of drugs and targets from Cancerrxgene\n",
    "2. Check for FDA listing\n",
    "    1. Collect indications_of_usage, mechanism_of_action, openfda.brand_name, openfda.generic_name\n",
    "3. Derive tissue from information"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(265, 5)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug ID</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Synonyms</th>\n",
       "      <th>Target</th>\n",
       "      <th>Target Pathway</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Erlotinib</td>\n",
       "      <td>Tarceva, RG-1415, CP-358774, OSI-774, Ro-50823...</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>3</td>\n",
       "      <td>Rapamycin</td>\n",
       "      <td>AY-22989, Sirolimus, WY-090217, Torisel, Rapamune</td>\n",
       "      <td>MTORC1</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5</td>\n",
       "      <td>Sunitinib</td>\n",
       "      <td>Sutent, Sunitinib Malate, SU-11248</td>\n",
       "      <td>PDGFR, KIT, VEGFR, FLT3, RET, CSF1R</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>PHA-665752</td>\n",
       "      <td>PHA665752, PHA 665752</td>\n",
       "      <td>MET</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>MG-132</td>\n",
       "      <td>LLL cpd, MG 132, MG132</td>\n",
       "      <td>Proteasome, CAPN1</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Drug ID   Drug Name                                           Synonyms  \\\n",
       "0        1   Erlotinib  Tarceva, RG-1415, CP-358774, OSI-774, Ro-50823...   \n",
       "1        3   Rapamycin  AY-22989, Sirolimus, WY-090217, Torisel, Rapamune   \n",
       "2        5   Sunitinib                 Sutent, Sunitinib Malate, SU-11248   \n",
       "3        6  PHA-665752                              PHA665752, PHA 665752   \n",
       "4        9      MG-132                             LLL cpd, MG 132, MG132   \n",
       "\n",
       "                                Target                     Target Pathway  \n",
       "0                                 EGFR                     EGFR signaling  \n",
       "1                               MTORC1                PI3K/MTOR signaling  \n",
       "2  PDGFR, KIT, VEGFR, FLT3, RET, CSF1R                      RTK signaling  \n",
       "3                                  MET                      RTK signaling  \n",
       "4                    Proteasome, CAPN1  Protein stability and degradation  "
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('Cancerrxgene/screened-compounds.xlsx')\n",
    "print df.shape; df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Query drug name in OpenFDA for additional information"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100% |########################################################################|\n"
     ]
    }
   ],
   "source": [
    "info = defaultdict(list)\n",
    "\n",
    "bar = ProgressBar()\n",
    "for i in bar(xrange(len(df))):\n",
    "    row = df.iloc[i]\n",
    "    \n",
    "    # Collect all aliases for Drug\n",
    "    aliases = row.Synonyms.split(', ') if type(row.Synonyms) == list else [str(row.Synonyms)]\n",
    "    aliases = None if 'nan' in aliases[0].lower() else aliases\n",
    "    drug = [str(row['Drug Name']).split()[0]]\n",
    "    aliases =  drug + aliases if aliases else drug\n",
    "    \n",
    "    # Check if any aliases return OpenFDA results\n",
    "    r = None\n",
    "    for name in aliases:\n",
    "        if not '-' in name:\n",
    "            r = openfda_drug_label(str(name))\n",
    "            if r: break\n",
    "    \n",
    "    # If no results\n",
    "    features  = ['usage', 'mech_action', 'brand_name', 'generic_name']\n",
    "    if not r:\n",
    "        #print 'No query for: {}'.format(row['Drug Name'])\n",
    "        for f in features:\n",
    "            info[f].append(None)\n",
    "    \n",
    "    else:\n",
    "        # Pull out result\n",
    "        e = r.json(object_hook=Expando)['results'][0]\n",
    "        \n",
    "        for f, a in zip(features, ['indications_and_usage', 'mechanism_of_action', \n",
    "                         'openfda.brand_name', 'openfda.generic_name']):    \n",
    "            try:\n",
    "                attribute = e[a] if not a.startswith('openfda') else e['openfda'][a.split('.')[1]]\n",
    "                info[f].append('. '.join(attribute))\n",
    "            except KeyError:\n",
    "                info[f].append(None)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Add values to dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df['usage'] = info['usage']\n",
    "df['mech_action'] = info['mech_action']\n",
    "df['brand_name'] = info['brand_name']\n",
    "df['generic_name'] = info['generic_name']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug ID</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Synonyms</th>\n",
       "      <th>Target</th>\n",
       "      <th>Target Pathway</th>\n",
       "      <th>usage</th>\n",
       "      <th>mech_action</th>\n",
       "      <th>brand_name</th>\n",
       "      <th>generic_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Erlotinib</td>\n",
       "      <td>Tarceva, RG-1415, CP-358774, OSI-774, Ro-50823...</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1. INDICATIONS AND USAGE Enter section text he...</td>\n",
       "      <td>12.1 Mechanism of Action The mechanism of clin...</td>\n",
       "      <td>Tarceva</td>\n",
       "      <td>ERLOTINIB HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>3</td>\n",
       "      <td>Rapamycin</td>\n",
       "      <td>AY-22989, Sirolimus, WY-090217, Torisel, Rapamune</td>\n",
       "      <td>MTORC1</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5</td>\n",
       "      <td>Sunitinib</td>\n",
       "      <td>Sutent, Sunitinib Malate, SU-11248</td>\n",
       "      <td>PDGFR, KIT, VEGFR, FLT3, RET, CSF1R</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE SUTENT is a kinase inh...</td>\n",
       "      <td>12.1 Mechanism of Action Sunitinib is a small ...</td>\n",
       "      <td>SUTENT</td>\n",
       "      <td>SUNITINIB MALATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>PHA-665752</td>\n",
       "      <td>PHA665752, PHA 665752</td>\n",
       "      <td>MET</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>MG-132</td>\n",
       "      <td>LLL cpd, MG 132, MG132</td>\n",
       "      <td>Proteasome, CAPN1</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Drug ID   Drug Name                                           Synonyms  \\\n",
       "0        1   Erlotinib  Tarceva, RG-1415, CP-358774, OSI-774, Ro-50823...   \n",
       "1        3   Rapamycin  AY-22989, Sirolimus, WY-090217, Torisel, Rapamune   \n",
       "2        5   Sunitinib                 Sutent, Sunitinib Malate, SU-11248   \n",
       "3        6  PHA-665752                              PHA665752, PHA 665752   \n",
       "4        9      MG-132                             LLL cpd, MG 132, MG132   \n",
       "\n",
       "                                Target                     Target Pathway  \\\n",
       "0                                 EGFR                     EGFR signaling   \n",
       "1                               MTORC1                PI3K/MTOR signaling   \n",
       "2  PDGFR, KIT, VEGFR, FLT3, RET, CSF1R                      RTK signaling   \n",
       "3                                  MET                      RTK signaling   \n",
       "4                    Proteasome, CAPN1  Protein stability and degradation   \n",
       "\n",
       "                                               usage  \\\n",
       "0  1. INDICATIONS AND USAGE Enter section text he...   \n",
       "1                                               None   \n",
       "2  1 INDICATIONS AND USAGE SUTENT is a kinase inh...   \n",
       "3                                               None   \n",
       "4                                               None   \n",
       "\n",
       "                                         mech_action brand_name  \\\n",
       "0  12.1 Mechanism of Action The mechanism of clin...    Tarceva   \n",
       "1                                               None       None   \n",
       "2  12.1 Mechanism of Action Sunitinib is a small ...     SUTENT   \n",
       "3                                               None       None   \n",
       "4                                               None       None   \n",
       "\n",
       "              generic_name  \n",
       "0  ERLOTINIB HYDROCHLORIDE  \n",
       "1                     None  \n",
       "2         SUNITINIB MALATE  \n",
       "3                     None  \n",
       "4                     None  "
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Drop rows whose generic or brand name does not match the drug name or synonyms"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "rows_to_drop = []\n",
    "for i in xrange(len(df)):\n",
    "    row = df.iloc[i]\n",
    "    aliases = row.Synonyms.split(', ') if type(row.Synonyms) == list else [str(row.Synonyms)]\n",
    "    drug = [str(row['Drug Name']).split()[0]]\n",
    "    aliases =  drug + aliases if aliases else drug\n",
    "    \n",
    "    # If missing brand and generic name, drop\n",
    "    if not row.generic_name and not row.brand_name:\n",
    "        rows_to_drop.append(i)\n",
    "        continue\n",
    "    \n",
    "    # If drug name or synonyms don't match, drop\n",
    "    if not any([x for x in aliases if x.lower() in row.generic_name.lower()]):\n",
    "        if not any([x for x in aliases if x.lower() in row.brand_name.lower()]):\n",
    "            rows_to_drop.append(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Drug ID</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Synonyms</th>\n",
       "      <th>Target</th>\n",
       "      <th>Target Pathway</th>\n",
       "      <th>usage</th>\n",
       "      <th>mech_action</th>\n",
       "      <th>brand_name</th>\n",
       "      <th>generic_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>Erlotinib</td>\n",
       "      <td>Tarceva, RG-1415, CP-358774, OSI-774, Ro-50823...</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1. INDICATIONS AND USAGE Enter section text he...</td>\n",
       "      <td>12.1 Mechanism of Action The mechanism of clin...</td>\n",
       "      <td>Tarceva</td>\n",
       "      <td>ERLOTINIB HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5</td>\n",
       "      <td>Sunitinib</td>\n",
       "      <td>Sutent, Sunitinib Malate, SU-11248</td>\n",
       "      <td>PDGFR, KIT, VEGFR, FLT3, RET, CSF1R</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE SUTENT is a kinase inh...</td>\n",
       "      <td>12.1 Mechanism of Action Sunitinib is a small ...</td>\n",
       "      <td>SUTENT</td>\n",
       "      <td>SUNITINIB MALATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>11</td>\n",
       "      <td>Paclitaxel</td>\n",
       "      <td>BMS-181339-01, Taxol, Onxol, Paxene, Praxel, A...</td>\n",
       "      <td>Microtubule stabiliser</td>\n",
       "      <td>Mitosis</td>\n",
       "      <td>INDICATIONS AND USAGE Paclitaxel Injection is ...</td>\n",
       "      <td>None</td>\n",
       "      <td>paclitaxel</td>\n",
       "      <td>PACLITAXEL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>30</td>\n",
       "      <td>Sorafenib</td>\n",
       "      <td>Nexavar, 284461-73-0, BAY 43-9006</td>\n",
       "      <td>PDGFR, KIT, VEGFR, RAF</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE NEXAVAR is a kinase in...</td>\n",
       "      <td>12.1 Mechanism of Action Sorafenib is a kinase...</td>\n",
       "      <td>Nexavar</td>\n",
       "      <td>SORAFENIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>34</td>\n",
       "      <td>Imatinib</td>\n",
       "      <td>Gleevec, STI-571</td>\n",
       "      <td>ABL, KIT, PDGFR</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE Imatinib mesylate is a...</td>\n",
       "      <td>12.1 Mechanism of Action Imatinib mesylate is ...</td>\n",
       "      <td>imatinib mesylate</td>\n",
       "      <td>IMATINIB MESYLATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>37</td>\n",
       "      <td>Crizotinib</td>\n",
       "      <td>Xalkori, PF2341066, PF-2341066, PF 2341066</td>\n",
       "      <td>MET, ALK, ROS1</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE XALKORI is indicated f...</td>\n",
       "      <td>12.1 Mechanism of Action Crizotinib is an inhi...</td>\n",
       "      <td>Xalkori</td>\n",
       "      <td>CRIZOTINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>51</td>\n",
       "      <td>Dasatinib</td>\n",
       "      <td>BMS-354825-03, BMS-354825, Sprycel</td>\n",
       "      <td>ABL, SRC, Ephrins, PDGFR, KIT</td>\n",
       "      <td>Other</td>\n",
       "      <td>1 INDICATIONS AND USAGE SPRYCEL® (dasatinib) i...</td>\n",
       "      <td>12.1 Mechanism of Action Dasatinib, at nanomol...</td>\n",
       "      <td>SPRYCEL</td>\n",
       "      <td>DASATINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>64</td>\n",
       "      <td>CMK</td>\n",
       "      <td>KIN001-128</td>\n",
       "      <td>RSK2</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "      <td>Indications and usage Indications and usage: 1...</td>\n",
       "      <td>None</td>\n",
       "      <td>THE YEON CMK PORE BLEMISH BC 02 NATURAL BEIGE</td>\n",
       "      <td>TITANIUM DIOXIDE, OCTINOXATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>71</td>\n",
       "      <td>Pyrimethamine</td>\n",
       "      <td>Daraprim, Chloridine</td>\n",
       "      <td>Dihydrofolate reductase (DHFR)</td>\n",
       "      <td>Other</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Pyrimethamine Leucovorin</td>\n",
       "      <td>PYRIMETHAMINE LEUCOVORIN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>104</td>\n",
       "      <td>Bortezomib</td>\n",
       "      <td>PS-341, LDP-341, Velcade</td>\n",
       "      <td>Proteasome</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "      <td>1 INDICATIONS AND USAGE VELCADE is a proteasom...</td>\n",
       "      <td>12.1 Mechanism of Action Bortezomib is a rever...</td>\n",
       "      <td>VELCADE</td>\n",
       "      <td>BORTEZOMIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>119</td>\n",
       "      <td>Lapatinib</td>\n",
       "      <td>Tykerb, Tyverb</td>\n",
       "      <td>ERBB2, EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE TYKERB® is indicated i...</td>\n",
       "      <td>12.1 Mechanism of Action Lapatinib is a 4-anil...</td>\n",
       "      <td>TYKERB</td>\n",
       "      <td>LAPATINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>133</td>\n",
       "      <td>Doxorubicin</td>\n",
       "      <td>Doxil, Rubex, Adriamycin, Adriablastin, Doxoru...</td>\n",
       "      <td>Anthracycline</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>1 INDICATIONS AND USAGE Doxorubicin hydrochlor...</td>\n",
       "      <td>12.1 Mechanism of Action The cytotoxic effect ...</td>\n",
       "      <td>Doxorubicin Hydrochloride</td>\n",
       "      <td>DOXORUBICIN HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>134</td>\n",
       "      <td>Etoposide</td>\n",
       "      <td>Etopophos, Vepesid, Eposin, VP-16</td>\n",
       "      <td>TOP2</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>INDICATIONS AND USAGE Etoposide Injection USP ...</td>\n",
       "      <td>None</td>\n",
       "      <td>Etoposide</td>\n",
       "      <td>ETOPOSIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>135</td>\n",
       "      <td>Gemcitabine</td>\n",
       "      <td>Gemzar, LY-188011</td>\n",
       "      <td>Pyrimidine antimetabolite</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>1 INDICATIONS AND USAGE Gemcitabine for Inject...</td>\n",
       "      <td>None</td>\n",
       "      <td>GEMCITABINE Hydrochloride</td>\n",
       "      <td>GEMCITABINE HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>140</td>\n",
       "      <td>Vinorelbine</td>\n",
       "      <td>vinorelbine tartrate, Navelbine, Exelbine</td>\n",
       "      <td>Microtubule destabiliser</td>\n",
       "      <td>Mitosis</td>\n",
       "      <td>1 INDICATIONS AND USAGE Vinorelbine Injection,...</td>\n",
       "      <td>12.1 Mechanism of Action Vinorelbine is a vinc...</td>\n",
       "      <td>VINORELBINE</td>\n",
       "      <td>VINORELBINE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>150</td>\n",
       "      <td>Bicalutamide</td>\n",
       "      <td>ICI-176334, Casodex, Cosudex, ICI 176334</td>\n",
       "      <td>AR</td>\n",
       "      <td>Hormone-related</td>\n",
       "      <td>1 INDICATIONS AND USAGE Bicalutamide 50 mg dai...</td>\n",
       "      <td>12.1 Mechanism of Action Bicalutamide is a non...</td>\n",
       "      <td>Bicalutamide</td>\n",
       "      <td>BICALUTAMIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>155</td>\n",
       "      <td>Ponatinib</td>\n",
       "      <td>AP24534, AP-24534, KIN001-192, Iclusig</td>\n",
       "      <td>ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE Iclusig (ponatinib) is...</td>\n",
       "      <td>12.1 Mechanism of Action Ponatinib is a kinase...</td>\n",
       "      <td>Iclusig</td>\n",
       "      <td>PONATINIB HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>186</td>\n",
       "      <td>Bexarotene</td>\n",
       "      <td>LG-100069, Targretin, Targret, Targrexin, Targ...</td>\n",
       "      <td>Retinioic X receptor (RXR) agonist</td>\n",
       "      <td>Other</td>\n",
       "      <td>1 INDICATIONS AND USAGE TARGRETIN® (bexarotene...</td>\n",
       "      <td>12.1 Mechanism of Action Bexarotene selectivel...</td>\n",
       "      <td>Targretin</td>\n",
       "      <td>BEXAROTENE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>190</td>\n",
       "      <td>Bleomycin</td>\n",
       "      <td>-</td>\n",
       "      <td>dsDNA break induction</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>INDICATIONS AND USAGE Bleomycin for injection ...</td>\n",
       "      <td>None</td>\n",
       "      <td>Bleomycin</td>\n",
       "      <td>BLEOMYCIN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>199</td>\n",
       "      <td>Pazopanib</td>\n",
       "      <td>Votrient</td>\n",
       "      <td>CSF1R, KIT,  PDGFRA, PDGFRB</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE VOTRIENT® is indicated...</td>\n",
       "      <td>12.1 Mechanism of Action Pazopanib is a multi-...</td>\n",
       "      <td>VOTRIENT</td>\n",
       "      <td>PAZOPANIB HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>206</td>\n",
       "      <td>Ruxolitinib</td>\n",
       "      <td>INCB-18424, Ruxolitinib Phosphate, Jakafi</td>\n",
       "      <td>JAK1, JAK2</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>1. INDICATIONS AND USAGE Jakafi is a kinase in...</td>\n",
       "      <td>12.1 Mechanism of Action Ruxolitinib, a kinase...</td>\n",
       "      <td>JAKAFI</td>\n",
       "      <td>RUXOLITINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>238</td>\n",
       "      <td>Idelalisib</td>\n",
       "      <td>CAL-101, Zydelig</td>\n",
       "      <td>PI3Kdelta</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE Zydelig is a kinase in...</td>\n",
       "      <td>12.1 Mechanism of Action Idelalisib is an inhi...</td>\n",
       "      <td>Zydelig</td>\n",
       "      <td>IDELALISIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>249</td>\n",
       "      <td>Cabozantinib</td>\n",
       "      <td>BMS-907351, XL-184, Cometriq</td>\n",
       "      <td>VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>1 INDICATIONS AND USAGE COMETRIQ is indicated ...</td>\n",
       "      <td>12.1 Mechanism of Action In vitro biochemical ...</td>\n",
       "      <td>COMETRIQ</td>\n",
       "      <td>CABOZANTINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>274</td>\n",
       "      <td>Belinostat</td>\n",
       "      <td>PXD101, PXD-101</td>\n",
       "      <td>HDAC1</td>\n",
       "      <td>Chromatin histone acetylation</td>\n",
       "      <td>1 INDICATIONS AND USAGE Beleodaq is indicated ...</td>\n",
       "      <td>12.1 Mechanism of Action Beleodaq is a histone...</td>\n",
       "      <td>Beleodaq</td>\n",
       "      <td>BELINOSTAT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>281</td>\n",
       "      <td>Alectinib</td>\n",
       "      <td>CH5424802, CH 542802, Alecensa</td>\n",
       "      <td>ALK</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE ALECENSA is indicated ...</td>\n",
       "      <td>12.1 Mechanism of Action Alectinib is a tyrosi...</td>\n",
       "      <td>ALECENSA</td>\n",
       "      <td>ALECTINIB HYDROCHLORIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>1004</td>\n",
       "      <td>Vinblastine</td>\n",
       "      <td>Velban</td>\n",
       "      <td>Microtubule destabiliser</td>\n",
       "      <td>Mitosis</td>\n",
       "      <td>INDICATIONS AND USAGE: Vinblastine Sulfate Inj...</td>\n",
       "      <td>None</td>\n",
       "      <td>Vinblastine Sulfate</td>\n",
       "      <td>VINBLASTINE SULFATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>1005</td>\n",
       "      <td>Cisplatin</td>\n",
       "      <td>cis-Diammineplatinum(II) dichloride, Platinol,...</td>\n",
       "      <td>DNA crosslinker</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>INDICATIONS AND USAGE Cisplatin injection is i...</td>\n",
       "      <td>None</td>\n",
       "      <td>Cisplatin</td>\n",
       "      <td>CISPLATIN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>1006</td>\n",
       "      <td>Cytarabine</td>\n",
       "      <td>Ara-Cytidine, Arabinosyl Cytosine, U-19920</td>\n",
       "      <td>Antimetabolite</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>INDICATIONS AND USAGE Cytarabine in combinatio...</td>\n",
       "      <td>None</td>\n",
       "      <td>Cytarabine</td>\n",
       "      <td>CYTARABINE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>1007</td>\n",
       "      <td>Docetaxel</td>\n",
       "      <td>RP-56976, Taxotere</td>\n",
       "      <td>Microtubule stabiliser</td>\n",
       "      <td>Mitosis</td>\n",
       "      <td>1. INDICATIONS AND USAGE Docetaxel Injection, ...</td>\n",
       "      <td>12.1 Mechanism of Action Docetaxel is an antin...</td>\n",
       "      <td>Docetaxel</td>\n",
       "      <td>DOCETAXEL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>1008</td>\n",
       "      <td>Methotrexate</td>\n",
       "      <td>Abitrexate, Amethopterin, Rheumatrex, Trexall,...</td>\n",
       "      <td>Antimetabolite</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>INDICATIONS AND USAGE Neoplastic Diseases Meth...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHOTREXATE</td>\n",
       "      <td>METHOTREXATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>1009</td>\n",
       "      <td>Tretinoin</td>\n",
       "      <td>ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita</td>\n",
       "      <td>Retinoic acid</td>\n",
       "      <td>Other</td>\n",
       "      <td>1 INDICATIONS AND USAGE Retin-A Micro® (tretin...</td>\n",
       "      <td>12.1 Mechanism of Action Although tretinoin ac...</td>\n",
       "      <td>Retin-A MICRO</td>\n",
       "      <td>TRETINOIN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>1010</td>\n",
       "      <td>Gefitinib</td>\n",
       "      <td>ZD-1839, Iressa</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE IRESSA is indicated fo...</td>\n",
       "      <td>12.1 Mechanism of Action The epidermal growth ...</td>\n",
       "      <td>IRESSA</td>\n",
       "      <td>GEFITINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>1012</td>\n",
       "      <td>Vorinostat</td>\n",
       "      <td>Zolinza, SAHA, suberanilohydroxamic acid, sube...</td>\n",
       "      <td>HDAC inhibitor Class I, IIa, IIb, IV</td>\n",
       "      <td>Chromatin histone acetylation</td>\n",
       "      <td>1 INDICATIONS AND USAGE ZOLINZA ® is indicated...</td>\n",
       "      <td>12.1 Mechanism of Action Vorinostat inhibits t...</td>\n",
       "      <td>ZOLINZA</td>\n",
       "      <td>VORINOSTAT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>1013</td>\n",
       "      <td>Nilotinib</td>\n",
       "      <td>Tasigna, AMN 107</td>\n",
       "      <td>ABL</td>\n",
       "      <td>ABL signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE Tasigna is a kinase in...</td>\n",
       "      <td>12.1 Mechanism of Action Nilotinib is an inhib...</td>\n",
       "      <td>Tasigna</td>\n",
       "      <td>NILOTINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>1016</td>\n",
       "      <td>Temsirolimus</td>\n",
       "      <td>CCI-779, Torisel</td>\n",
       "      <td>MTOR</td>\n",
       "      <td>PI3K/MTOR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE TORISEL is indicated f...</td>\n",
       "      <td>12.1 Mechanism of Action Temsirolimus is an in...</td>\n",
       "      <td>Torisel</td>\n",
       "      <td>TEMSIROLIMUS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>1017</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>AZD2281, KU0059436,  Lynparza</td>\n",
       "      <td>PARP1, PARP2</td>\n",
       "      <td>Genome integrity</td>\n",
       "      <td>1 INDICATIONS AND USAGE Lynparza is a poly (AD...</td>\n",
       "      <td>12.1 Mechanism of Action Lynparza is an inhibi...</td>\n",
       "      <td>Lynparza</td>\n",
       "      <td>OLAPARIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>1019</td>\n",
       "      <td>Bosutinib</td>\n",
       "      <td>SKI-606, Bosulif</td>\n",
       "      <td>SRC, ABL, TEC</td>\n",
       "      <td>Other, kinases</td>\n",
       "      <td>1 INDICATIONS AND USAGE BOSULIF is indicated f...</td>\n",
       "      <td>12.1 Mechanism of Action Bosutinib is a tyrosi...</td>\n",
       "      <td>BOSULIF</td>\n",
       "      <td>BOSUTINIB MONOHYDRATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>1020</td>\n",
       "      <td>Lenalidomide</td>\n",
       "      <td>CDC-501, CC-5013, Revlimid</td>\n",
       "      <td>CRBN</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "      <td>1 INDICATIONS AND USAGE REVLIMID is a thalidom...</td>\n",
       "      <td>12.1 Mechanism of Action Lenalidomide is an an...</td>\n",
       "      <td>Revlimid</td>\n",
       "      <td>LENALIDOMIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>1021</td>\n",
       "      <td>Axitinib</td>\n",
       "      <td>AG-13736, Inlyta</td>\n",
       "      <td>PDGFR, KIT, VEGFR</td>\n",
       "      <td>RTK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE INLYTA is indicated fo...</td>\n",
       "      <td>12.1 Mechanism of Action Axitinib has been sho...</td>\n",
       "      <td>INLYTA</td>\n",
       "      <td>AXITINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>1032</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>BIBW2992, Tovok, Gilotrif</td>\n",
       "      <td>ERBB2, EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE GILOTRIF is a kinase i...</td>\n",
       "      <td>12.1 Mechanism of Action Afatinib covalently b...</td>\n",
       "      <td>Gilotrif</td>\n",
       "      <td>AFATINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>1033</td>\n",
       "      <td>Vismodegib</td>\n",
       "      <td>GDC0449, Erivedge</td>\n",
       "      <td>SMO</td>\n",
       "      <td>Other</td>\n",
       "      <td>1 INDICATIONS AND USAGE ERIVEDGE capsule is in...</td>\n",
       "      <td>12.1 Mechanism of Action Vismodegib is an inhi...</td>\n",
       "      <td>ERIVEDGE</td>\n",
       "      <td>VISMODEGIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>1054</td>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>PD0332991, PD-0332991, PF-00080665-73</td>\n",
       "      <td>CDK4, CDK6</td>\n",
       "      <td>Cell cycle</td>\n",
       "      <td>1 INDICATIONS AND USAGE IBRANCE is indicated i...</td>\n",
       "      <td>12.1 Mechanism of Action Palbociclib is an inh...</td>\n",
       "      <td>Ibrance</td>\n",
       "      <td>PALBOCICLIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>1114</td>\n",
       "      <td>Cetuximab</td>\n",
       "      <td>Erbitux, IMC-C225, C225, IMC-225, L01XC06</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE Erbitux® is an epiderm...</td>\n",
       "      <td>12.1 Mechanism of Action The epidermal growth ...</td>\n",
       "      <td>ERBITUX</td>\n",
       "      <td>CETUXIMAB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>1175</td>\n",
       "      <td>Rucaparib</td>\n",
       "      <td>PF-01367338, AG-014699, AG-14447, AG-14699</td>\n",
       "      <td>PARP1, PARP2</td>\n",
       "      <td>Genome integrity</td>\n",
       "      <td>1 INDICATIONS AND USAGE Rubraca™ is indicated ...</td>\n",
       "      <td>12.1 Mechanism of Action Rucaparib is an inhib...</td>\n",
       "      <td>Rubraca</td>\n",
       "      <td>RUCAPARIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>1199</td>\n",
       "      <td>Tamoxifen</td>\n",
       "      <td>Nolvadex, Soltamox, Zynoplex, ICI-46474, Kessar</td>\n",
       "      <td>ESR1</td>\n",
       "      <td>Hormone-related</td>\n",
       "      <td>INDICATIONS AND USAGE Metastatic Breast Cancer...</td>\n",
       "      <td>None</td>\n",
       "      <td>Tamoxifen Citrate</td>\n",
       "      <td>TAMOXIFEN CITRATE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>1372</td>\n",
       "      <td>Trametinib</td>\n",
       "      <td>GSK1120212, Mekinist</td>\n",
       "      <td>MEK1, MEK2</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE MEKINIST is a kinase i...</td>\n",
       "      <td>12.1 Mechanism of Action Trametinib is a rever...</td>\n",
       "      <td>Mekinist</td>\n",
       "      <td>TRAMETINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>1373</td>\n",
       "      <td>Dabrafenib</td>\n",
       "      <td>GSK2118436, Tafinlar</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE •TAFINLAR is a kinase ...</td>\n",
       "      <td>12.1 Mechanism of Action Dabrafenib is an inhi...</td>\n",
       "      <td>Tafinlar</td>\n",
       "      <td>DABRAFENIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>1375</td>\n",
       "      <td>Temozolomide</td>\n",
       "      <td>Temodar, Temodal, M-39831, SCH 52365</td>\n",
       "      <td>DNA alkylating agent</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>1 INDICATIONS AND USAGE TEMODAR is an alkylati...</td>\n",
       "      <td>12.1 Mechanism of Action Temozolomide is not d...</td>\n",
       "      <td>TEMODAR</td>\n",
       "      <td>TEMOZOLOMIDE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>1377</td>\n",
       "      <td>Afatinib</td>\n",
       "      <td>BIBW2992, Tovok, Gilotrif</td>\n",
       "      <td>ERBB2, EGFR</td>\n",
       "      <td>EGFR signaling</td>\n",
       "      <td>1 INDICATIONS AND USAGE GILOTRIF is a kinase i...</td>\n",
       "      <td>12.1 Mechanism of Action Afatinib covalently b...</td>\n",
       "      <td>Gilotrif</td>\n",
       "      <td>AFATINIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>1378</td>\n",
       "      <td>Bleomycin (50 uM)</td>\n",
       "      <td>-</td>\n",
       "      <td>dsDNA break induction</td>\n",
       "      <td>DNA replication</td>\n",
       "      <td>INDICATIONS AND USAGE Bleomycin for injection ...</td>\n",
       "      <td>None</td>\n",
       "      <td>Bleomycin</td>\n",
       "      <td>BLEOMYCIN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>1495</td>\n",
       "      <td>Olaparib</td>\n",
       "      <td>AZD2281, KU0059436,  Lynparza</td>\n",
       "      <td>PARP1, PARP2</td>\n",
       "      <td>Genome integrity</td>\n",
       "      <td>1 INDICATIONS AND USAGE Lynparza is a poly (AD...</td>\n",
       "      <td>12.1 Mechanism of Action Lynparza is an inhibi...</td>\n",
       "      <td>Lynparza</td>\n",
       "      <td>OLAPARIB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>1502</td>\n",
       "      <td>Bicalutamide</td>\n",
       "      <td>ICI-176334, Casodex, Cosudex, ICI 176334</td>\n",
       "      <td>AR</td>\n",
       "      <td>Hormone-related</td>\n",
       "      <td>1 INDICATIONS AND USAGE Bicalutamide 50 mg dai...</td>\n",
       "      <td>12.1 Mechanism of Action Bicalutamide is a non...</td>\n",
       "      <td>Bicalutamide</td>\n",
       "      <td>BICALUTAMIDE</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Drug ID          Drug Name  \\\n",
       "0          1          Erlotinib   \n",
       "2          5          Sunitinib   \n",
       "5         11         Paclitaxel   \n",
       "8         30          Sorafenib   \n",
       "10        34           Imatinib   \n",
       "12        37         Crizotinib   \n",
       "16        51          Dasatinib   \n",
       "26        64                CMK   \n",
       "27        71      Pyrimethamine   \n",
       "35       104         Bortezomib   \n",
       "39       119          Lapatinib   \n",
       "41       133        Doxorubicin   \n",
       "42       134          Etoposide   \n",
       "43       135        Gemcitabine   \n",
       "45       140        Vinorelbine   \n",
       "47       150       Bicalutamide   \n",
       "52       155          Ponatinib   \n",
       "75       186         Bexarotene   \n",
       "76       190          Bleomycin   \n",
       "82       199          Pazopanib   \n",
       "89       206        Ruxolitinib   \n",
       "105      238         Idelalisib   \n",
       "107      249       Cabozantinib   \n",
       "126      274         Belinostat   \n",
       "131      281          Alectinib   \n",
       "169     1004        Vinblastine   \n",
       "170     1005          Cisplatin   \n",
       "171     1006         Cytarabine   \n",
       "172     1007          Docetaxel   \n",
       "173     1008       Methotrexate   \n",
       "174     1009          Tretinoin   \n",
       "175     1010          Gefitinib   \n",
       "177     1012         Vorinostat   \n",
       "178     1013          Nilotinib   \n",
       "181     1016       Temsirolimus   \n",
       "182     1017           Olaparib   \n",
       "184     1019          Bosutinib   \n",
       "185     1020       Lenalidomide   \n",
       "186     1021           Axitinib   \n",
       "196     1032           Afatinib   \n",
       "197     1033         Vismodegib   \n",
       "210     1054        Palbociclib   \n",
       "222     1114          Cetuximab   \n",
       "233     1175          Rucaparib   \n",
       "236     1199          Tamoxifen   \n",
       "253     1372         Trametinib   \n",
       "254     1373         Dabrafenib   \n",
       "255     1375       Temozolomide   \n",
       "256     1377           Afatinib   \n",
       "257     1378  Bleomycin (50 uM)   \n",
       "259     1495           Olaparib   \n",
       "261     1502       Bicalutamide   \n",
       "\n",
       "                                              Synonyms  \\\n",
       "0    Tarceva, RG-1415, CP-358774, OSI-774, Ro-50823...   \n",
       "2                   Sutent, Sunitinib Malate, SU-11248   \n",
       "5    BMS-181339-01, Taxol, Onxol, Paxene, Praxel, A...   \n",
       "8                    Nexavar, 284461-73-0, BAY 43-9006   \n",
       "10                                    Gleevec, STI-571   \n",
       "12          Xalkori, PF2341066, PF-2341066, PF 2341066   \n",
       "16                  BMS-354825-03, BMS-354825, Sprycel   \n",
       "26                                          KIN001-128   \n",
       "27                                Daraprim, Chloridine   \n",
       "35                            PS-341, LDP-341, Velcade   \n",
       "39                                      Tykerb, Tyverb   \n",
       "41   Doxil, Rubex, Adriamycin, Adriablastin, Doxoru...   \n",
       "42                   Etopophos, Vepesid, Eposin, VP-16   \n",
       "43                                   Gemzar, LY-188011   \n",
       "45           vinorelbine tartrate, Navelbine, Exelbine   \n",
       "47            ICI-176334, Casodex, Cosudex, ICI 176334   \n",
       "52              AP24534, AP-24534, KIN001-192, Iclusig   \n",
       "75   LG-100069, Targretin, Targret, Targrexin, Targ...   \n",
       "76                                                   -   \n",
       "82                                            Votrient   \n",
       "89           INCB-18424, Ruxolitinib Phosphate, Jakafi   \n",
       "105                                   CAL-101, Zydelig   \n",
       "107                       BMS-907351, XL-184, Cometriq   \n",
       "126                                    PXD101, PXD-101   \n",
       "131                     CH5424802, CH 542802, Alecensa   \n",
       "169                                             Velban   \n",
       "170  cis-Diammineplatinum(II) dichloride, Platinol,...   \n",
       "171         Ara-Cytidine, Arabinosyl Cytosine, U-19920   \n",
       "172                                 RP-56976, Taxotere   \n",
       "173  Abitrexate, Amethopterin, Rheumatrex, Trexall,...   \n",
       "174   ATRA, Vesanoid, Renova, Atralin, Tretin-X, Avita   \n",
       "175                                    ZD-1839, Iressa   \n",
       "177  Zolinza, SAHA, suberanilohydroxamic acid, sube...   \n",
       "178                                   Tasigna, AMN 107   \n",
       "181                                   CCI-779, Torisel   \n",
       "182                      AZD2281, KU0059436,  Lynparza   \n",
       "184                                   SKI-606, Bosulif   \n",
       "185                         CDC-501, CC-5013, Revlimid   \n",
       "186                                   AG-13736, Inlyta   \n",
       "196                          BIBW2992, Tovok, Gilotrif   \n",
       "197                                  GDC0449, Erivedge   \n",
       "210              PD0332991, PD-0332991, PF-00080665-73   \n",
       "222          Erbitux, IMC-C225, C225, IMC-225, L01XC06   \n",
       "233         PF-01367338, AG-014699, AG-14447, AG-14699   \n",
       "236    Nolvadex, Soltamox, Zynoplex, ICI-46474, Kessar   \n",
       "253                               GSK1120212, Mekinist   \n",
       "254                               GSK2118436, Tafinlar   \n",
       "255               Temodar, Temodal, M-39831, SCH 52365   \n",
       "256                          BIBW2992, Tovok, Gilotrif   \n",
       "257                                                  -   \n",
       "259                      AZD2281, KU0059436,  Lynparza   \n",
       "261           ICI-176334, Casodex, Cosudex, ICI 176334   \n",
       "\n",
       "                                               Target  \\\n",
       "0                                                EGFR   \n",
       "2                 PDGFR, KIT, VEGFR, FLT3, RET, CSF1R   \n",
       "5                              Microtubule stabiliser   \n",
       "8                              PDGFR, KIT, VEGFR, RAF   \n",
       "10                                    ABL, KIT, PDGFR   \n",
       "12                                     MET, ALK, ROS1   \n",
       "16                      ABL, SRC, Ephrins, PDGFR, KIT   \n",
       "26                                               RSK2   \n",
       "27                     Dihydrofolate reductase (DHFR)   \n",
       "35                                         Proteasome   \n",
       "39                                        ERBB2, EGFR   \n",
       "41                                      Anthracycline   \n",
       "42                                               TOP2   \n",
       "43                          Pyrimidine antimetabolite   \n",
       "45                           Microtubule destabiliser   \n",
       "47                                                 AR   \n",
       "52        ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3   \n",
       "75                 Retinioic X receptor (RXR) agonist   \n",
       "76                              dsDNA break induction   \n",
       "82                        CSF1R, KIT,  PDGFRA, PDGFRB   \n",
       "89                                         JAK1, JAK2   \n",
       "105                                         PI3Kdelta   \n",
       "107  VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL   \n",
       "126                                             HDAC1   \n",
       "131                                               ALK   \n",
       "169                          Microtubule destabiliser   \n",
       "170                                   DNA crosslinker   \n",
       "171                                    Antimetabolite   \n",
       "172                            Microtubule stabiliser   \n",
       "173                                    Antimetabolite   \n",
       "174                                     Retinoic acid   \n",
       "175                                              EGFR   \n",
       "177              HDAC inhibitor Class I, IIa, IIb, IV   \n",
       "178                                               ABL   \n",
       "181                                              MTOR   \n",
       "182                                      PARP1, PARP2   \n",
       "184                                     SRC, ABL, TEC   \n",
       "185                                              CRBN   \n",
       "186                                 PDGFR, KIT, VEGFR   \n",
       "196                                       ERBB2, EGFR   \n",
       "197                                               SMO   \n",
       "210                                        CDK4, CDK6   \n",
       "222                                              EGFR   \n",
       "233                                      PARP1, PARP2   \n",
       "236                                              ESR1   \n",
       "253                                        MEK1, MEK2   \n",
       "254                                              BRAF   \n",
       "255                              DNA alkylating agent   \n",
       "256                                       ERBB2, EGFR   \n",
       "257                             dsDNA break induction   \n",
       "259                                      PARP1, PARP2   \n",
       "261                                                AR   \n",
       "\n",
       "                        Target Pathway  \\\n",
       "0                       EGFR signaling   \n",
       "2                        RTK signaling   \n",
       "5                              Mitosis   \n",
       "8                        RTK signaling   \n",
       "10                       RTK signaling   \n",
       "12                       RTK signaling   \n",
       "16                               Other   \n",
       "26                  ERK MAPK signaling   \n",
       "27                               Other   \n",
       "35   Protein stability and degradation   \n",
       "39                      EGFR signaling   \n",
       "41                     DNA replication   \n",
       "42                     DNA replication   \n",
       "43                     DNA replication   \n",
       "45                             Mitosis   \n",
       "47                     Hormone-related   \n",
       "52                       RTK signaling   \n",
       "75                               Other   \n",
       "76                     DNA replication   \n",
       "82                       RTK signaling   \n",
       "89                      Other, kinases   \n",
       "105                PI3K/MTOR signaling   \n",
       "107                     Other, kinases   \n",
       "126      Chromatin histone acetylation   \n",
       "131                      RTK signaling   \n",
       "169                            Mitosis   \n",
       "170                    DNA replication   \n",
       "171                    DNA replication   \n",
       "172                            Mitosis   \n",
       "173                    DNA replication   \n",
       "174                              Other   \n",
       "175                     EGFR signaling   \n",
       "177      Chromatin histone acetylation   \n",
       "178                      ABL signaling   \n",
       "181                PI3K/MTOR signaling   \n",
       "182                   Genome integrity   \n",
       "184                     Other, kinases   \n",
       "185  Protein stability and degradation   \n",
       "186                      RTK signaling   \n",
       "196                     EGFR signaling   \n",
       "197                              Other   \n",
       "210                         Cell cycle   \n",
       "222                     EGFR signaling   \n",
       "233                   Genome integrity   \n",
       "236                    Hormone-related   \n",
       "253                 ERK MAPK signaling   \n",
       "254                 ERK MAPK signaling   \n",
       "255                    DNA replication   \n",
       "256                     EGFR signaling   \n",
       "257                    DNA replication   \n",
       "259                   Genome integrity   \n",
       "261                    Hormone-related   \n",
       "\n",
       "                                                 usage  \\\n",
       "0    1. INDICATIONS AND USAGE Enter section text he...   \n",
       "2    1 INDICATIONS AND USAGE SUTENT is a kinase inh...   \n",
       "5    INDICATIONS AND USAGE Paclitaxel Injection is ...   \n",
       "8    1 INDICATIONS AND USAGE NEXAVAR is a kinase in...   \n",
       "10   1 INDICATIONS AND USAGE Imatinib mesylate is a...   \n",
       "12   1 INDICATIONS AND USAGE XALKORI is indicated f...   \n",
       "16   1 INDICATIONS AND USAGE SPRYCEL® (dasatinib) i...   \n",
       "26   Indications and usage Indications and usage: 1...   \n",
       "27                                                None   \n",
       "35   1 INDICATIONS AND USAGE VELCADE is a proteasom...   \n",
       "39   1 INDICATIONS AND USAGE TYKERB® is indicated i...   \n",
       "41   1 INDICATIONS AND USAGE Doxorubicin hydrochlor...   \n",
       "42   INDICATIONS AND USAGE Etoposide Injection USP ...   \n",
       "43   1 INDICATIONS AND USAGE Gemcitabine for Inject...   \n",
       "45   1 INDICATIONS AND USAGE Vinorelbine Injection,...   \n",
       "47   1 INDICATIONS AND USAGE Bicalutamide 50 mg dai...   \n",
       "52   1 INDICATIONS AND USAGE Iclusig (ponatinib) is...   \n",
       "75   1 INDICATIONS AND USAGE TARGRETIN® (bexarotene...   \n",
       "76   INDICATIONS AND USAGE Bleomycin for injection ...   \n",
       "82   1 INDICATIONS AND USAGE VOTRIENT® is indicated...   \n",
       "89   1. INDICATIONS AND USAGE Jakafi is a kinase in...   \n",
       "105  1 INDICATIONS AND USAGE Zydelig is a kinase in...   \n",
       "107  1 INDICATIONS AND USAGE COMETRIQ is indicated ...   \n",
       "126  1 INDICATIONS AND USAGE Beleodaq is indicated ...   \n",
       "131  1 INDICATIONS AND USAGE ALECENSA is indicated ...   \n",
       "169  INDICATIONS AND USAGE: Vinblastine Sulfate Inj...   \n",
       "170  INDICATIONS AND USAGE Cisplatin injection is i...   \n",
       "171  INDICATIONS AND USAGE Cytarabine in combinatio...   \n",
       "172  1. INDICATIONS AND USAGE Docetaxel Injection, ...   \n",
       "173  INDICATIONS AND USAGE Neoplastic Diseases Meth...   \n",
       "174  1 INDICATIONS AND USAGE Retin-A Micro® (tretin...   \n",
       "175  1 INDICATIONS AND USAGE IRESSA is indicated fo...   \n",
       "177  1 INDICATIONS AND USAGE ZOLINZA ® is indicated...   \n",
       "178  1 INDICATIONS AND USAGE Tasigna is a kinase in...   \n",
       "181  1 INDICATIONS AND USAGE TORISEL is indicated f...   \n",
       "182  1 INDICATIONS AND USAGE Lynparza is a poly (AD...   \n",
       "184  1 INDICATIONS AND USAGE BOSULIF is indicated f...   \n",
       "185  1 INDICATIONS AND USAGE REVLIMID is a thalidom...   \n",
       "186  1 INDICATIONS AND USAGE INLYTA is indicated fo...   \n",
       "196  1 INDICATIONS AND USAGE GILOTRIF is a kinase i...   \n",
       "197  1 INDICATIONS AND USAGE ERIVEDGE capsule is in...   \n",
       "210  1 INDICATIONS AND USAGE IBRANCE is indicated i...   \n",
       "222  1 INDICATIONS AND USAGE Erbitux® is an epiderm...   \n",
       "233  1 INDICATIONS AND USAGE Rubraca™ is indicated ...   \n",
       "236  INDICATIONS AND USAGE Metastatic Breast Cancer...   \n",
       "253  1 INDICATIONS AND USAGE MEKINIST is a kinase i...   \n",
       "254  1 INDICATIONS AND USAGE •TAFINLAR is a kinase ...   \n",
       "255  1 INDICATIONS AND USAGE TEMODAR is an alkylati...   \n",
       "256  1 INDICATIONS AND USAGE GILOTRIF is a kinase i...   \n",
       "257  INDICATIONS AND USAGE Bleomycin for injection ...   \n",
       "259  1 INDICATIONS AND USAGE Lynparza is a poly (AD...   \n",
       "261  1 INDICATIONS AND USAGE Bicalutamide 50 mg dai...   \n",
       "\n",
       "                                           mech_action  \\\n",
       "0    12.1 Mechanism of Action The mechanism of clin...   \n",
       "2    12.1 Mechanism of Action Sunitinib is a small ...   \n",
       "5                                                 None   \n",
       "8    12.1 Mechanism of Action Sorafenib is a kinase...   \n",
       "10   12.1 Mechanism of Action Imatinib mesylate is ...   \n",
       "12   12.1 Mechanism of Action Crizotinib is an inhi...   \n",
       "16   12.1 Mechanism of Action Dasatinib, at nanomol...   \n",
       "26                                                None   \n",
       "27                                                None   \n",
       "35   12.1 Mechanism of Action Bortezomib is a rever...   \n",
       "39   12.1 Mechanism of Action Lapatinib is a 4-anil...   \n",
       "41   12.1 Mechanism of Action The cytotoxic effect ...   \n",
       "42                                                None   \n",
       "43                                                None   \n",
       "45   12.1 Mechanism of Action Vinorelbine is a vinc...   \n",
       "47   12.1 Mechanism of Action Bicalutamide is a non...   \n",
       "52   12.1 Mechanism of Action Ponatinib is a kinase...   \n",
       "75   12.1 Mechanism of Action Bexarotene selectivel...   \n",
       "76                                                None   \n",
       "82   12.1 Mechanism of Action Pazopanib is a multi-...   \n",
       "89   12.1 Mechanism of Action Ruxolitinib, a kinase...   \n",
       "105  12.1 Mechanism of Action Idelalisib is an inhi...   \n",
       "107  12.1 Mechanism of Action In vitro biochemical ...   \n",
       "126  12.1 Mechanism of Action Beleodaq is a histone...   \n",
       "131  12.1 Mechanism of Action Alectinib is a tyrosi...   \n",
       "169                                               None   \n",
       "170                                               None   \n",
       "171                                               None   \n",
       "172  12.1 Mechanism of Action Docetaxel is an antin...   \n",
       "173                                               None   \n",
       "174  12.1 Mechanism of Action Although tretinoin ac...   \n",
       "175  12.1 Mechanism of Action The epidermal growth ...   \n",
       "177  12.1 Mechanism of Action Vorinostat inhibits t...   \n",
       "178  12.1 Mechanism of Action Nilotinib is an inhib...   \n",
       "181  12.1 Mechanism of Action Temsirolimus is an in...   \n",
       "182  12.1 Mechanism of Action Lynparza is an inhibi...   \n",
       "184  12.1 Mechanism of Action Bosutinib is a tyrosi...   \n",
       "185  12.1 Mechanism of Action Lenalidomide is an an...   \n",
       "186  12.1 Mechanism of Action Axitinib has been sho...   \n",
       "196  12.1 Mechanism of Action Afatinib covalently b...   \n",
       "197  12.1 Mechanism of Action Vismodegib is an inhi...   \n",
       "210  12.1 Mechanism of Action Palbociclib is an inh...   \n",
       "222  12.1 Mechanism of Action The epidermal growth ...   \n",
       "233  12.1 Mechanism of Action Rucaparib is an inhib...   \n",
       "236                                               None   \n",
       "253  12.1 Mechanism of Action Trametinib is a rever...   \n",
       "254  12.1 Mechanism of Action Dabrafenib is an inhi...   \n",
       "255  12.1 Mechanism of Action Temozolomide is not d...   \n",
       "256  12.1 Mechanism of Action Afatinib covalently b...   \n",
       "257                                               None   \n",
       "259  12.1 Mechanism of Action Lynparza is an inhibi...   \n",
       "261  12.1 Mechanism of Action Bicalutamide is a non...   \n",
       "\n",
       "                                        brand_name  \\\n",
       "0                                          Tarceva   \n",
       "2                                           SUTENT   \n",
       "5                                       paclitaxel   \n",
       "8                                          Nexavar   \n",
       "10                               imatinib mesylate   \n",
       "12                                         Xalkori   \n",
       "16                                         SPRYCEL   \n",
       "26   THE YEON CMK PORE BLEMISH BC 02 NATURAL BEIGE   \n",
       "27                        Pyrimethamine Leucovorin   \n",
       "35                                         VELCADE   \n",
       "39                                          TYKERB   \n",
       "41                       Doxorubicin Hydrochloride   \n",
       "42                                       Etoposide   \n",
       "43                       GEMCITABINE Hydrochloride   \n",
       "45                                     VINORELBINE   \n",
       "47                                    Bicalutamide   \n",
       "52                                         Iclusig   \n",
       "75                                       Targretin   \n",
       "76                                       Bleomycin   \n",
       "82                                        VOTRIENT   \n",
       "89                                          JAKAFI   \n",
       "105                                        Zydelig   \n",
       "107                                       COMETRIQ   \n",
       "126                                       Beleodaq   \n",
       "131                                       ALECENSA   \n",
       "169                            Vinblastine Sulfate   \n",
       "170                                      Cisplatin   \n",
       "171                                     Cytarabine   \n",
       "172                                      Docetaxel   \n",
       "173                                   METHOTREXATE   \n",
       "174                                  Retin-A MICRO   \n",
       "175                                         IRESSA   \n",
       "177                                        ZOLINZA   \n",
       "178                                        Tasigna   \n",
       "181                                        Torisel   \n",
       "182                                       Lynparza   \n",
       "184                                        BOSULIF   \n",
       "185                                       Revlimid   \n",
       "186                                         INLYTA   \n",
       "196                                       Gilotrif   \n",
       "197                                       ERIVEDGE   \n",
       "210                                        Ibrance   \n",
       "222                                        ERBITUX   \n",
       "233                                        Rubraca   \n",
       "236                              Tamoxifen Citrate   \n",
       "253                                       Mekinist   \n",
       "254                                       Tafinlar   \n",
       "255                                        TEMODAR   \n",
       "256                                       Gilotrif   \n",
       "257                                      Bleomycin   \n",
       "259                                       Lynparza   \n",
       "261                                   Bicalutamide   \n",
       "\n",
       "                     generic_name  \n",
       "0         ERLOTINIB HYDROCHLORIDE  \n",
       "2                SUNITINIB MALATE  \n",
       "5                      PACLITAXEL  \n",
       "8                       SORAFENIB  \n",
       "10              IMATINIB MESYLATE  \n",
       "12                     CRIZOTINIB  \n",
       "16                      DASATINIB  \n",
       "26   TITANIUM DIOXIDE, OCTINOXATE  \n",
       "27       PYRIMETHAMINE LEUCOVORIN  \n",
       "35                     BORTEZOMIB  \n",
       "39                      LAPATINIB  \n",
       "41      DOXORUBICIN HYDROCHLORIDE  \n",
       "42                      ETOPOSIDE  \n",
       "43      GEMCITABINE HYDROCHLORIDE  \n",
       "45                    VINORELBINE  \n",
       "47                   BICALUTAMIDE  \n",
       "52        PONATINIB HYDROCHLORIDE  \n",
       "75                     BEXAROTENE  \n",
       "76                      BLEOMYCIN  \n",
       "82        PAZOPANIB HYDROCHLORIDE  \n",
       "89                    RUXOLITINIB  \n",
       "105                    IDELALISIB  \n",
       "107                  CABOZANTINIB  \n",
       "126                    BELINOSTAT  \n",
       "131       ALECTINIB HYDROCHLORIDE  \n",
       "169           VINBLASTINE SULFATE  \n",
       "170                     CISPLATIN  \n",
       "171                    CYTARABINE  \n",
       "172                     DOCETAXEL  \n",
       "173                  METHOTREXATE  \n",
       "174                     TRETINOIN  \n",
       "175                     GEFITINIB  \n",
       "177                    VORINOSTAT  \n",
       "178                     NILOTINIB  \n",
       "181                  TEMSIROLIMUS  \n",
       "182                      OLAPARIB  \n",
       "184         BOSUTINIB MONOHYDRATE  \n",
       "185                  LENALIDOMIDE  \n",
       "186                      AXITINIB  \n",
       "196                      AFATINIB  \n",
       "197                    VISMODEGIB  \n",
       "210                   PALBOCICLIB  \n",
       "222                     CETUXIMAB  \n",
       "233                     RUCAPARIB  \n",
       "236             TAMOXIFEN CITRATE  \n",
       "253                    TRAMETINIB  \n",
       "254                    DABRAFENIB  \n",
       "255                  TEMOZOLOMIDE  \n",
       "256                      AFATINIB  \n",
       "257                     BLEOMYCIN  \n",
       "259                      OLAPARIB  \n",
       "261                  BICALUTAMIDE  "
      ]
     },
     "execution_count": 110,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.drop(rows_to_drop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
